No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX241213P87000
- 0.25
- +0.08+47.06%
15min DelayClose Dec 10 16:00 ET
0.25High0.19Low
0.19Open0.17Pre Close5 Volume34 Open Interest87.00Strike Price107.00Turnover33.16%IV3.82%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.0876Delta0.0651Gamma902.00Leverage Ratio-0.0694Theta-0.0005Rho-79.04Eff Leverage0.0117Vega
Intraday
- 5D
- Daily
News
CICC Initiates Boston Scientific at Outperform With $116 Price Target
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
Boston Scientific's Promising Clinical Trials and Innovative Approaches Justify Buy Rating
Boston Scientific Is Maintained at Buy by Canaccord Genuity
Unusual Options Activity: BABA, ADT and Others Attract Market Bets, BABA V/OI Ratio Reaches 120.0
EST Dec 9th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $101